Jiang Zhong Pharmaceutical Co.,Ltd

Equities

600750

CNE000000M80

Pharmaceuticals

End-of-day quote Shanghai S.E. 06:00:00 2024-04-29 pm EDT 5-day change 1st Jan Change
26.66 CNY +0.41% Intraday chart for Jiang Zhong Pharmaceutical Co.,Ltd -2.70% +27.68%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Jiang Zhong Pharmaceutical Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Jiang Zhong Pharmaceutical Co.,Ltd Proposes Cash Dividend CI
Jiang Zhong Pharmaceutical Co.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2023 CI
GuangYuYuan Makes Leadership Reshuffle MT
Workshop of Jiang Zhong Pharmaceutical's Unit Passes Regulatory Inspection MT
Jiang Zhong Pharmaceutical to Buy Two Local Firms for 13.5 Million Yuan MT
Jiang Zhong Pharmaceutical Co.,Ltd agreed to acquire Jiangxi Jiang Zhong Changrun Pharmaceutical Co., Ltd./Jiangxi Jiang Zhong Changrun Pharmaceutical Co from Jiangxi Jiang Zhong Medicine Investment and Development Co., Ltd. for CNY13.5 million. CI
Jiang Zhong Pharmaceutical Co.,Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
Jiangzhong Pharmaceutical Unit's Ulcer Drug Passes Regulator's Consistency Evaluation MT
Jiang Zhong Pharmaceutical Co.,Ltd Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Jiangzhong Pharmaceutical's Q1 Net Profit Increases; Shares Rise 5% MT
Jiang Zhong Pharmaceutical Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Jiang Zhong Pharmaceutical Co.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Jiang Zhong Pharmaceutical's January-September Profit Increases MT
Jiang Zhong Pharmaceutical Co.,Ltd Reports Earnings Results for the Nine Months Ended September 30, 2022 CI
Jiangzhong Pharmaceutical Sees January-September Profit Rising 12%; Shares Drop 6% MT
China Resources Pharmaceutical Group Limited Provides Earnings Forecasts for the Nine Months Ended 30 September 2022 CI
Jiang Zhong Pharmaceutical Co.,Ltd Reports Earnings Results for the Half Year Ended June 30, 2022 CI
Jiangzhong Pharma Sees 26% Growth in H1 Profit MT
Jiang Zhong Pharmaceutical Co.,Ltd's Equity Buyback announced on June 18, 2021, has expired. CI
Jiang Zhong Pharmaceutical Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
Jiangzhong Pharma Sees 15% Growth in Q1 Profit; Shares Rise 3% MT
Jiang Zhong Pharmaceutical Co.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2021 CI
Jiangzhong Pharma Sees 11% Growth in Q1 Profit MT
Jiang Zhong Pharmaceutical Co.,Ltd Provides Earning Guidance for the Quarter Ended March 31, 2022 CI
Chart Jiang Zhong Pharmaceutical Co.,Ltd
More charts
JIANGZHONG PHARMACEUTICAL CO., LTD is a China-based company principally engaged in the manufacture, research and development and sales of over-the-counter (OTC) pharmaceuticals and healthcare products. The Company’s products include OTC medicines, healthcare products and functional food, as well as wine. Its OTC pharmaceuticals include indigestion tablets, lactobacillin tablets and sarcandra glabra tablets, among others. Its healthcare products and functional food include calcium tablets and ginseng products, among others. The Company mainly operates its businesses in domestic market.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
26.66 CNY
Average target price
31.12 CNY
Spread / Average Target
+16.73%
Consensus
  1. Stock Market
  2. Equities
  3. 600750 Stock
  4. News Jiang Zhong Pharmaceutical Co.,Ltd
  5. Workshop of Jiang Zhong Pharmaceutical's Unit Passes Regulatory Inspection